Constantine Stratakis is a Medical Genetics specialist and a Gastroenterologist in Bethesda, Maryland. Dr. Stratakis is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Cushing's disease, Neuroendocrine Tumor, Gastrointestinal Stromal Tumor, Orchiectomy, and Hormone Replacement Therapy (HRT).

Valerie Lee, M.D., is a medical oncologist with the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an instructor of medical oncology at Johns Hopkins University School of Medicine. Dr. Lee has an expertise in management of gastrointestinal malignancies, including gastric, colon and pancreatobiliary cancers. Dr. Lee earned her medical degree from the Columbia University College of Physicians and Surgeons. She completed a residency in internal medicine at New York Presbyterian Hospital, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine. Dr. Lee is currently earning her Certificate in Science of Clinical Investigation at Johns Hopkins Bloomberg School of Public Health. Dr. Lee is a member of the American Society of Clinical Oncology. Dr. Lee manages multiple early phase trials and her work has been published in peer-reviewed journals. Her research interests include clinical trials for patients with gastrointestinal malignancies, and combining traditional chemotherapies with immunotherapy to improve survival and quality of life for patients. She has received a Cancer Center Training grant for research on molecular targets for cancer detection and treatment and has spoken at numerous conferences on updates in gastrointestinal malignancies. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Pancreaticoduodenectomy.

Dr. Michail Mavros, a surgical oncologist specializing in complex cancers, is deeply committed to offering his patients personalized, advanced care. Originally from Athens, Greece, Dr. Mavros's passion for oncology was sparked during medical school after losing a close friend to cancer. This life-changing event inspired him to dedicate his career to improving the lives of cancer patients. Dr. Mavros is one of few surgeons with accredited subspecialty training in both complex surgical oncology and hepato-pancreato-biliary (HPB) surgery, making him highly qualified to treat cancers of the liver, pancreas, and bile ducts. He is also skilled in minimally invasive techniques, including laparoscopic and robotic-assisted surgery, which offer benefits such as faster recovery, reduced pain, and improved outcomes. At the heart of Dr. Mavros' approach is his belief in individualized care. He works closely with a multidisciplinary team of experts, including medical oncologists, radiation oncologists, and pathologists, to ensure each patient receives a thorough evaluation. This collaborative approach results in comprehensive, personalized treatment plans. By leveraging the latest advances in precision medicine, Dr. Mavros tailors his treatments to meet the unique needs of each patient, guided by the most current scientific research and evidence-based practices. Dr. Mavros is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Stephen R. Broderick, M.D., MPHS, is an assistant professor of surgery at Johns Hopkins University School of Medicine and a thoracic surgeon, part of a multidisciplinary team treating lung cancer patients in the Johns Hopkins Kimmel Cancer Center. Listen to Dr. Broderick's Cancer Matters podcast episode to learn more about his work. Dr. Broderick's primary clinical focus is at Sibley Memorial Hospital, in Washington, D.C. He also practices at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore, Maryland. Dr. Broderick has a clinical expertise in surgical treatment of lung cancer, esophageal cancer and other thoracic malignancies, as well as benign thoracic conditions. This includes achalasia, bronchoscopy, chest wall reconstruction and tumors, lung nodules and paraesophageal hernias. He has a clinical interest in minimally invasive surgery for lung cancer and the coordinated delivery of multidisciplinary care for thoracic oncology patients. Before joining Johns Hopkins, Dr. Broderick was a thoracic surgeon at St Luke’s Hospital, where he served as the medical director of the cardiothoracic intensive care unit and a member of the oncology steering committee. He also served as an instructor of surgery at Washington University School of Medicine. Dr. Broderick received his medical degree from Georgetown University School of Medicine in 2003 and he completed his internship and residency training in general surgery at New York-Presbyterian Hospital. He studied the molecular biology of lung cancer as a research fellow at Memorial Sloan Kettering Cancer Center, where he received the Chairman's Award for outstanding contributions to the basic science research fellowship. Dr. Broderick also completed a fellowship in thoracic surgery at Washington University School of Medicine in 2012 and earned a Masters in Population Health Science from Washington University School of Medicine in 2014. Dr. Broderick is a member of the American College of Chest Physicians, The Society of Thoracic Surgeons and the American Society of Clinical Oncology. Dr. Broderick’s research interests are focused on improving outcomes for lung cancer patients. He is particularly interested in studying how various treatments for early-stage lung cancer impact patients’ quality of life. Dr. Broderick has contributed to numerous publications and is a reviewer for the Journal of Cardiovascular and Thoracic Surgery, as well as Annals of Thoracic Surgery. Dr. Broderick is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Tubal Ligation, and Lung Transplant.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Joanna Klubo is an Endocrinologist in Washington, Washington, D.c.. Dr. Klubo is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Thyroid Cancer, Hypothyroidism, Thyroid Nodule, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Alexander Ling is a Radiologist in Bethesda, Maryland. Dr. Ling is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Adrenal Cancer, Chronic Granulomatous Disease, and Von Hippel-Lindau (VHL) Syndrome.

Dr. Bhagat is an interventional radiologist serving as the director of Vascular and Interventional Radiology of the National Capital Region. His primary areas of clinical expertise are interventional oncology (chemoembolization, radioembolization, and ablation), women's interventions, and vascular interventions (venous and arterial). Dr. Bhagat sees patients at both Suburban Hospital and Sibley Memorial Hospital. His research interests include interventional oncology, especially device development and software assistance for complex procedures. Dr. Bhagat successfully completed his Vascular and Interventional Radiology fellowship at the University of California, San Francisco in 2009. He joined the staff as an Assistant Professor of Radiology and Surgery at the Johns Hopkins University School of Medicine. While there, he authored more than 5 book chapters and 20 peer-reviewed manuscripts as well as giving many lectures at national and international meetings. In his second year at Johns Hopkins, he received a NIH R01 grant. Videos Nikhil Bhagat, M.D. Dr. Bhagat is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Ascites, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Liver Embolization, and Gastrostomy.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Deepa Galaiya is a fellowship-trained neurotologist and lateral skull base surgeon. Her clinical practice specializes in the surgical and medical treatment of middle ear, inner ear, skull base, and facial nerve disorders in children and adults. This includes treatment of skull base tumors, vestibular schwannomas (or acoustic neuromas), cochlear implants, chronic ear disease, hearing loss, cholesteatomas, otosclerosis, cerebrospinal fluid leaks, and eardrum perforations. She is trained in endoscopic ear surgery, a minimally invasive approach to treat cholesteatoma and eardrum perforations that reduce the need for visible incisions. She will be serving the patient population in the Baltimore and Washington, D.C., metro areas. Dr. Galaiya’s research interests include the development of a force-sensing microforceps for cochlear implantation to assess electrode insertion, tip foldover, and basilar membrane rupture. Her other projects involve computer vision for surgical navigation, tool-to-tissue registration for robotic temporal bone surgery, optimization of surgical ergonomics, and assessment of forces used in middle ear prosthesis placement with a cooperative control robotic arm. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Galaiya is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Patulous Eustachian Tube, Infant Hearing Loss, Angiomyoma, Mastoidectomy, and Tissue Biopsy.

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Andrew Akman, MD, MBA a native of Washington, DC, currently practices at Suburban Hospital, Sibley Hospital, and Johns Hopkins Hospital. Dr. Akman performs a variety of minimally invasive procedures. He has specific interest in complex IVC filter removals, interventional oncology, pulmonary embolism, and prostate artery embolization. Dr. Akman is an expert in complex IVC filter retrieval and IVC filter related complications. In addition to standard IVC filter retrievals, he removes devices that are severely tilted, embedded, or fractured, as well as those designated as permanent devices. He serves as an adviser to other physicians on complex techniques including laser sheath and forceps assisted retrieval. Within interventional oncology, Dr. Akman performs thermal ablation of lung, liver, and kidney tumors. He performs chemoembolization and radioembolization (Yttrium-90) on primary liver cancer and metastatic liver disease. Dr. Akman also performs prostate artery embolization, an emerging minimally invasive technique for treating urinary symptoms associated with prostate enlargement. Dr. Akman prides himself on building strong relationships with his patients and practicing patient-centered medicine. Videos Andrew Akman, M.D., Interventional Radiologist Recent News Articles and Media Coverage Honoring a Life By Helping Others, Johns Hopkins Medicine, (July 20, 2022). Dr. Akman is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Ascites, Ureterocele, Familial Pancreatic Cancer, Gastrostomy, and Liver Embolization.

Dr. Liebengood is a radiologist who specializes in cross-sectional imaging. Dr. Liebengood received her Bachelor of Arts from Johns Hopkins University in Baltimore, MD, followed by a Master of Health Services Administration at the University of Michigan, School of Public Health. She attended medical school and completed residency training at Rutgers-Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey. She went on to complete a body imaging fellowship at The Johns Hopkins Hospital, followed by the Armstrong Institute’s Leadership Program in Quality and Safety. She specializes in CT, MR, and Ultrasound. In addition to her clinical focus as a body imager, she has an interest in quality and safety. Dr. Liebengood is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Collapsed Lung, Diverticular Disease, Gallbladder Disease, and Thyroid Nodule.

Olaya Gutierrez is a Gastroenterologist in Washington, Washington, D.c.. Dr. Gutierrez is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Achalasia, Gastroesophageal Reflux Disease (GERD), Choledocholithiasis, Endoscopy, and Lithotripsy.

Dr. Susan Scott is a thoracic medical oncologist with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital and Assistant Professor of Oncology at the Johns Hopkins University School of Medicine. Dr. Scott has expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and pulmonary carcinoid tumors, as well as thymic malignancies. She leads the EGFR and HER2 lung cancer research program for Johns Hopkins. Dr. Scott received her undergraduate education at the University of Oxford, UK and medical doctorate from Yale University. She completed residency at the Cleveland Clinic where she also served as Chief Resident in Internal Medicine. Dr. Scott joined Johns Hopkins Oncology for fellowship training in Baltimore and was recruited to the thoracic oncology program to continue work as a physician and clinical scientist focused in lung cancer. Dr. Scott and her team are committed to providing compassionate and individualized care to their patients, including state-of-the-art therapies and clinical trials. Her research interests include clinical trials in resectable lung cancer, innovative applications of immunotherapy, and novel targeted therapies, especially EGFR- and HER2-mutated lung cancers. Dr. Scott is a member of the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and the International Association for the Study of Lung Cancer (IASLC). Dr. Scott is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and EGFR Positive Lung Cancer.

Melissa Blakeman, M.D., is the regional medical director for Johns Hopkins Community Physicians (JHCP) in the Maryland suburbs region. Dr. Blakeman practices internal medicine at JHCP in North Bethesda, Maryland, where she previously served as the office medical director. Dr. Blakeman serves as the Medical Director, Patient Access, for JHCP primary care. She is on several committees, including the Baldridge, Recruitment and Retention, Research and Projects, and Practice Standards Committees. Dr. Blakeman earned her medical degree from the University of Pittsburgh School of Medicine. She completed a residency in internal medicine at the George Washington University School of Medicine and was the chief resident for primary care. Dr. Blakeman has also completed Johns Hopkins Medicine's Transforming Health Systems for Accountable Care Executive Education Program and Leadership Development Program. Dr. Blakeman has been repeatedly named a Top Doctor by Washingtonian Magazine and Washington Consumers' Checkbook. Dr. Blakeman is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, Supranuclear Ophthalmoplegia, and Supranuclear Ocular Palsy.

John Marshall is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Marshall is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Hepatectomy, and Pancreatectomy.

Holly Dushkin is a Hematologist and a Hematologist Oncology provider in Chevy Chase, Maryland. Dr. Dushkin is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.